Federal contract award
75N95A25P00061
WARD LAB MEMBERS REQUIRES WHOLE PLASMID SEQUENCING, SANGER SEQUENCING, AND OLIGO SYNTHESIS IN ORDER TO CONTINUE ONGOING EXPERIMENTS AND ENSURE CONTINUITY OF RESEARCH IN THE LAB.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NINDS |
| NAICS | 541380 — Testing Laboratories and Services |
| PSC | Q301 — Reference Laboratory Testing |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $10.0K |
| Current contract value | $10.0K |
| Potential contract value / ceiling | $10.0K |
| Start date | May 29, 2025 |
| Current end date | May 28, 2026 |
| Potential end date | May 28, 2026 |
| Latest award activity | May 29, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 29, 2025 | 0 | $10.0K | WARD LAB MEMBERS REQUIRES WHOLE PLASMID SEQUENCING, SANGER SEQUENCING, AND OLIGO SYNTHESIS IN ORDER TO CONTINUE ONGOING EXPERIMENTS AND ENSURE CONTINUITY OF RESEARCH IN THE LAB. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.